Non Invasive Pressure Support Ventilation (NIPPV) Versus Recruitment Maneuver (RM) and Preoxygenation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00852384 |
Recruitment Status :
Completed
First Posted : February 27, 2009
Last Update Posted : August 28, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity | Procedure: NIPPV and IRM | Phase 4 |
Atelectasis formation during general anesthesia, leading to reduced end-expiratory lung volume, is an important cause of intrapulmonary shunt leading to impaired gas-exchange and hypoxemia. During general anesthesia and the immediate postoperative period, morbidly obese patients, who develop a larger amount of atelectasis than non-obese patient, are more likely to present impairment of gas exchange and respiratory mechanics. Noninvasive positive-pressure support ventilation (NIPPV) and positive end-expiratory pressure (PEEP) are effective to provide oxygenation during intubation of hypoxemic patients. Recent data suggest that NIPPV enhances preoxygenation in morbidly obese patients. Moreover, the application of PEEP during induction of anesthesia prevents atelectasis formation and increases nonhypoxic apnea duration in obese patients despite the use of high-inspired oxygen fraction. However, the use of both NIPPV is widely used in the operating room, because of technical and materials constraints.
Several trials have demonstrated that alveolar recruitment maneuvers (RM) are effective to remove atelectasis and improve lungs mechanics and gas-exchange.
The purpose of this randomized and controlled study is to compare the effects of two ventilatory strategies during anesthesia induction of morbidly obese patients on both gas-exchange and functional residual capacity (FRC) modifications: 1- Control group: preoxygenation using 100% O2 via a face-mask and PEEP 10 cmH2O after intubation; 2- NIPPV group: preoxygenation using NIPPV and PEEP 10 cmH2O after intubation; 3- RM group: preoxygenation using 100% O2 via a face-mask and early RM plus PEEP 10 cmH2O after intubation.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Official Title: | Non Invasive Pressure Support Ventilation (NIPPV) Versus Conventionnal Approach and Early Recruitment Maneuver (RM) for Preoxygenation of Morbidly Obese Patient |
Study Start Date : | February 2009 |
Actual Primary Completion Date : | August 2009 |
Actual Study Completion Date : | August 2009 |
- Procedure: NIPPV and IRM
- non invasive positive pressure support ventilation (NIPPV group)
- alveolar recruitment maneuver (IRM group)
- Oxygenation (PaO2) measured 5min after the onset of mechanical ventilation [ Time Frame: 5 min after the oneset of mechanical ventilation ]
- - FRC after tracheal intubation and after 5 min of mechanical ventilation [ Time Frame: after 5 min of mechanichal ventilation ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Body mass index (BMI > 30 kg/m2)
- Age > 18 years
- ASA I-III
Exclusion Criteria:
- Age < 18 years
- Patient refusal
- Pregnancy
- Emergency surgery
- COPD with FEV1 < 50%
- History of pneumothorax
- Severe asthma
- Cardiac failure (NYHA > 2)
- Ischemic heart disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00852384
France | |
University Hospital Hôtel-Dieu | |
Clermont-Ferrand, France, 63058 |
Principal Investigator: | Emmanuel Futier | University Hospital, Clermont-Ferrand | |
Study Director: | Jean-Michel Constantin | University Hospital, Clermont-Ferrand |
Responsible Party: | Emmanuel FUTIER, CHU Clermont-Ferrand |
ClinicalTrials.gov Identifier: | NCT00852384 |
Other Study ID Numbers: |
CHU-0046 |
First Posted: | February 27, 2009 Key Record Dates |
Last Update Posted: | August 28, 2009 |
Last Verified: | August 2009 |
Anesthesia induction Obese patients Noninvasive ventilation Alveolar recruitment |